{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:31:19Z","timestamp":1784043079393,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,9,7]],"date-time":"2008-09-07T00:00:00Z","timestamp":1220745600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,9,7]],"date-time":"2008-09-07T00:00:00Z","timestamp":1220745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1038\/nm.1864","type":"journal-article","created":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T03:23:52Z","timestamp":1221535432000},"page":"1118-1122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors"],"prefix":"10.1038","volume":"14","author":[{"given":"De-Xue","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Tanhehco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A","family":"Foss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja-Mun","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Fukayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sgouros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G","family":"Pomper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F","family":"Ambinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,7]]},"reference":[{"key":"BFnm1864_CR1","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1002\/cncr.22617","volume":"109","author":"TE Witzig","year":"2007","unstructured":"Witzig, T.E. et al. Long-term responses in patients with recurring or refractory B cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan. Cancer 109, 1804\u20131810 (2007).","journal-title":"Cancer"},{"key":"BFnm1864_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1056\/NEJMoa041511","volume":"352","author":"MS Kaminski","year":"2005","unstructured":"Kaminski, M.S. et al. 131I-tositumomab therapy as initial treatment for follicular lymphoma. N. Engl. J. Med. 352, 441\u2013449 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1864_CR3","first-page":"5144","volume":"52","author":"M Juweid","year":"1992","unstructured":"Juweid, M. et al. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Cancer Res. 52, 5144\u20135153 (1992).","journal-title":"Cancer Res."},{"key":"BFnm1864_CR4","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1128\/JVI.78.4.1893-1902.2004","volume":"78","author":"WH Feng","year":"2004","unstructured":"Feng, W.H., Hong, G., Delecluse, H.J. & Kenney, S.C. Lytic induction therapy for Epstein-Barr virus\u2013positive B cell lymphomas. J. Virol. 78, 1893\u20131902 (2004).","journal-title":"J. Virol."},{"key":"BFnm1864_CR5","first-page":"6126","volume":"55","author":"JG Tjuvajev","year":"1995","unstructured":"Tjuvajev, J.G. et al. Imaging the expression of transfected genes in vivo. Cancer Res. 55, 6126\u20136132 (1995).","journal-title":"Cancer Res."},{"key":"BFnm1864_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s002590050035","volume":"27","author":"R Haubner","year":"2000","unstructured":"Haubner, R., Avril, N., Hantzopoulos, P.A., Gansbacher, B. & Schwaiger, M. In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU. Eur. J. Nucl. Med. 27, 283\u2013291 (2000).","journal-title":"Eur. J. Nucl. Med."},{"key":"BFnm1864_CR7","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1158\/1078-0432.CCR-06-2295","volume":"13","author":"DX Fu","year":"2007","unstructured":"Fu, D.X. et al. Virus-associated tumor imaging by induction of viral gene expression. Clin. Cancer Res. 13, 1453\u20131458 (2007).","journal-title":"Clin. Cancer Res."},{"key":"BFnm1864_CR8","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1128\/AAC.45.7.2082-2091.2001","volume":"45","author":"SM Moore","year":"2001","unstructured":"Moore, S.M., Cannon, J.S., Tanhehco, Y.C., Hamzeh, F.M. & Ambinder, R.F. Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues. Antimicrob. Agents Chemother. 45, 2082\u20132091 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnm1864_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ijc.22275","volume":"120","author":"T Ushiku","year":"2007","unstructured":"Ushiku, T. et al. p73 gene promoter methylation in Epstein-Barr virus\u2013associated gastric carcinoma. Int. J. Cancer 120, 60\u201366 (2007).","journal-title":"Int. J. Cancer"},{"key":"BFnm1864_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin, D.M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74\u2013108 (2005).","journal-title":"CA Cancer J. Clin."},{"key":"BFnm1864_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/mp.53.5.255","volume":"53","author":"K Takada","year":"2000","unstructured":"Takada, K. Epstein-Barr virus and gastric carcinoma. Mol. Pathol. 53, 255\u2013261 (2000).","journal-title":"Mol. Pathol."},{"key":"BFnm1864_CR12","doi-asserted-by":"publisher","first-page":"6825","DOI":"10.1128\/JVI.76.13.6825-6831.2002","volume":"76","author":"JM Chong","year":"2002","unstructured":"Chong, J.M. et al. Interleukin-1\u03b2 expression in human gastric carcinoma with Epstein-Barr virus infection. J. Virol. 76, 6825\u20136831 (2002).","journal-title":"J. Virol."},{"key":"BFnm1864_CR13","first-page":"163","volume":"43","author":"RG Blasberg","year":"1999","unstructured":"Blasberg, R.G. & Tjuvajev, J.G. Herpes simplex virus thymidine kinase as a marker\/reporter gene for PET imaging of gene therapy. Q. J. Nucl. Med. 43, 163\u2013169 (1999).","journal-title":"Q. J. Nucl. Med."},{"key":"BFnm1864_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11307-007-0078-3","volume":"9","author":"ML Schipper","year":"2007","unstructured":"Schipper, M.L., Goris, M.L. & Gambhir, S.S. Evaluation of herpes simplex virus 1 thymidine kinase-mediated trapping of 131I FIAU and prodrug activation of ganciclovir as a synergistic cancer radio\/chemotherapy. Mol. Imaging Biol. 9, 110\u2013116 (2007).","journal-title":"Mol. Imaging Biol."},{"key":"BFnm1864_CR15","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1182\/blood-2006-01-024703","volume":"109","author":"SP Perrine","year":"2007","unstructured":"Perrine, S.P. et al. A phase 1\/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus\u2013associated lymphoid malignancies. Blood 109, 2571\u20132578 (2007).","journal-title":"Blood"},{"key":"BFnm1864_CR16","first-page":"260","volume":"44","author":"G Sgouros","year":"2003","unstructured":"Sgouros, G. et al. Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I\u2013anti-B1 antibody: assessment of tumor dose response. J. Nucl. Med. 44, 260\u2013268 (2003).","journal-title":"J. Nucl. Med."},{"key":"BFnm1864_CR17","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJM199510263331702","volume":"333","author":"R McKenzie","year":"1995","unstructured":"McKenzie, R. et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N. Engl. J. Med. 333, 1099\u20131105 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1864_CR18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1172\/JCI117698","volume":"95","author":"L Cui","year":"1995","unstructured":"Cui, L., Yoon, S., Schinazi, R.F. & Sommadossi, J.P. Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-\u03b2-d-arabinofuranosyl)-5-iodouracil in human liver cells. J. Clin. Invest. 95, 555\u2013563 (1995).","journal-title":"J. Clin. Invest."},{"key":"BFnm1864_CR19","doi-asserted-by":"publisher","first-page":"40847","DOI":"10.1074\/jbc.M106743200","volume":"276","author":"AA Johnson","year":"2001","unstructured":"Johnson, A.A. et al. Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. J. Biol. Chem. 276, 40847\u201340857 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnm1864_CR20","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1073\/pnas.93.8.3592","volume":"93","author":"W Lewis","year":"1996","unstructured":"Lewis, W. et al. Fialuridine and its metabolites inhibit DNA polymerase\u03b3 at sites of multiple adjacent analog incorporation, decrease mtDNA abundance and cause mitochondrial structural defects in cultured hepatoblasts. Proc. Natl. Acad. Sci. USA 93, 3592\u20133597 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1864_CR21","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1371\/journal.pone.0001007","volume":"2","author":"LA Diaz","year":"2007","unstructured":"Diaz, L.A. et al. Imaging of musculoskeletal bacterial infections by [I]FIAU-PET\/CT. PLoS ONE 2, e1007 (2007).","journal-title":"PLoS ONE"},{"key":"BFnm1864_CR22","first-page":"467","volume":"42","author":"A Jacobs","year":"2001","unstructured":"Jacobs, A. et al. Quantitative kinetics of [124I]FIAU in cat and man. J. Nucl. Med. 42, 467\u2013475 (2001).","journal-title":"J. Nucl. Med."},{"key":"BFnm1864_CR23","first-page":"5781","volume":"60","author":"EM Westphal","year":"2000","unstructured":"Westphal, E.M., Blackstock, W., Feng, W., Israel, B. & Kenney, S.C. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies. Cancer Res. 60, 5781\u20135788 (2000).","journal-title":"Cancer Res."},{"key":"BFnm1864_CR24","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/sj.gt.3302487","volume":"12","author":"BG Gentry","year":"2005","unstructured":"Gentry, B.G., Im, M., Boucher, P.D., Ruch, R.J. & Shewach, D.S. GCV phosphates are transferred between HeLa cells despite lack of bystander cytotoxicity. Gene Ther. 12, 1033\u20131041 (2005).","journal-title":"Gene Ther."},{"key":"BFnm1864_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2407-5-32","volume":"5","author":"PA Robe","year":"2005","unstructured":"Robe, P.A. et al. Dexamethasone inhibits the HSV-tk\/ganciclovir bystander effect in malignant glioma cells. BMC Cancer 5, 32 (2005).","journal-title":"BMC Cancer"},{"key":"BFnm1864_CR26","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/00006231-200309000-00002","volume":"24","author":"KL Dixon","year":"2003","unstructured":"Dixon, K.L. The radiation biology of radioimmunotherapy. Nucl. Med. Commun. 24, 951\u2013957 (2003).","journal-title":"Nucl. Med. Commun."},{"key":"BFnm1864_CR27","first-page":"150","volume":"48","author":"H Song","year":"2007","unstructured":"Song, H. et al. Therapeutic potential of 90Y- and 131I-labeled anti-CD20 monoclonal antibody in treating non-Hodgkin's lymphoma with pulmonary involvement: a Monte Carlo-based dosimetric analysis. J. Nucl. Med. 48, 150\u2013157 (2007).","journal-title":"J. Nucl. Med."},{"key":"BFnm1864_CR28","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1128\/JVI.75.10.4482-4489.2001","volume":"75","author":"A Rodriguez","year":"2001","unstructured":"Rodriguez, A., Jung, E.J. & Flemington, E.K. Cell cycle analysis of Epstein-Barr virus\u2013infected cells following treatment with lytic cycle\u2013inducing agents. J. Virol. 75, 4482\u20134489 (2001).","journal-title":"J. Virol."},{"key":"BFnm1864_CR29","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1128\/JVI.77.2.1481-1500.2003","volume":"77","author":"FY Wu","year":"2003","unstructured":"Wu, F.Y. et al. CCAAT\/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G1 cell cycle arrest during the Epstein-Barr virus lytic cycle. J. Virol. 77, 1481\u20131500 (2003).","journal-title":"J. Virol."},{"key":"BFnm1864_CR30","doi-asserted-by":"publisher","first-page":"9590","DOI":"10.1128\/JVI.77.17.9590-9612.2003","volume":"77","author":"SE Wang","year":"2003","unstructured":"Wang, S.E., Wu, F.Y., Yu, Y. & Hayward, G.S. CCAAT\/enhancer-binding protein-\u03b1 is induced during the early stages of Kaposi's sarcoma\u2013associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA and PAN promoters. J. Virol. 77, 9590\u20139612 (2003).","journal-title":"J. Virol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.1864.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.1864","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.1864.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:22:31Z","timestamp":1684434151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.1864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,7]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["BFnm1864"],"URL":"https:\/\/doi.org\/10.1038\/nm.1864","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1141952.599062","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,7]]},"assertion":[{"value":"6 February 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}